MEngSc Biopharmaceutical Engineering

Graduate Taught (level 9 nfq, credits 90)

This Masters provides substantial coverage of scientific, technical, management and regulatory issues associated with this industry and offers an internationally recognised high quality flexible curriculum, which follows the latest developments in science and technology. This programme is suitable for Science and Engineering graduates wishing to obtain a qualification which is highly relevant to the biopharmaceutical industry.

Excellent employment record
This programme has an excellent employment record. This Masters results in an internationally recognised graduate qualification that provides graduates with the knowledge and skills required to gain high level professional jobs in the biopharmaceutical and pharmaceutical sector.

Facilities and Resources
This programme is closely linked with the NIBRT facility. NIBRT offers a quality training and research experience not previously possible anywhere in the world. At the heart of the NIBRT building is the bioprocessing pilot plant, consisting of extensive upstream, downstream, fill-finish and the associated analytical facilities. These facilities are all operated in a realistic GMP simulated, operational manufacturing environment.

 

Full Time option suitable for:

Domestic(EEA) applicants: Yes
International (Non EEA) applicants currently residing outside of the EEA Region. Yes

Part Time option suitable for:

Domestic(EEA) applicants: Yes
International (Non EEA) applicants currently residing outside of the EEA Region. No

Your career opportunities upon graduation from this programme are exemplary. Ireland is a world player in pharmaceutical and biopharmaceutical production.

The pharmaceutical industry in Ireland comprises a mix of international and local companies. Approximately, 120 overseas companies have plants in Ireland, including many of largest pharmaceutical and biopharmaceutical companies in the world including Pfizer, GSK, Merck, AbbVie, Novartis, Jansen Biologics (Ireland), Biomarin, Roche, Sanofi Genzyme and many more. Upon graduation from this programme, you will enjoy an extremely high job placement rate with superlative career opportunities.

MEngSc Biopharmaceutical Engineering (T015) Part Time
EU          Year 1 - € 3940
EU          Year 2 - € 3940
EU          Year 3 - € 1910

MEngSc Biopharmaceutical Engineering (T070) Full Time
EU          fee per year - € 7490
nonEU    fee per year - € 23800

***Fees are subject to change
Tuition fee information is available on the UCD Fees website. Please note that UCD offers a number of graduate scholarships for full-time, self-funding international students, holding an offer of a place on a UCD graduate degree programme. For further information please see International Scholarships.

  • A 4-year bachelors degree with a minimum upper second class honours (NFQ level 8) or international equivalence in a relevant Engineering, Science or Technology programme.
  • Applicants whose first language is not English must also demonstrate English language proficiency of IELTS 6.5 (no band less than 6.0 in each element), or equivalent.

  • Kate McCarthy, Amgen.

    An Undergraduate Degree in Medicinal Chemistry meant I had a detailed knowledge of how drugs interact at a cellular level. I recognised that I wanted to know more about the Biopharmaceutical industry and this Masters course provided me with that knowledge; it bridged the gap between the science behind the drug and the manufacturing process. 

    The modules I studied such as lean six sigma, regulatory affairs, GMP, facility design & bioseparations were a brilliant platform providing me with the means to obtain a manufacturing role within industry. Not only was the theory taught exceptionally well but also the practical training carried out in the NIBRT facility within the UCD Campus allowed for a means of putting theory into practice and gave a great insight into the processes carried out within a typical Biopharmaceutical plant. I would highly recommend this course to anyone looking to broaden their career opportunities as well as their understanding of the industry.

  • MEngSc Chemical Engineering
  • MSc Biotechnology

  • The following entry routes are available:

    MEngSc Biopharmaceutical Engineering FT (T070)
    Duration
    1 Years
    Attendance
    Full Time
    Deadline
    Rolling *
    MEngSc Biopharmaceutical Engineering PT (T015)
    Duration
    2 Years
    Attendance
    Part Time
    Deadline
    Rolling *

    * Courses will remain open until such time as all places have been filled, therefore early application is advised